We are live on ! Find out more
BGIM

Boussard & Gavaudan Investment Management Portfolio holdings

AUM $1.06B
1-Year Est. Return 4.58%
This Fund
S&P 500
This Quarter Est. Return
-3.43%
1 Year Est. Return
+4.58%
3 Year Est. Return
+25.82%
5 Year Est. Return
+33.18%
10 Year Est. Return
+356.42%
AUM
$1.18M
AUM Growth
-$1.05B
Cap. Flow
-$403M
Cap. Flow %
-34,025.24%
Top 10 Hldgs %
51.44%
Holding
164
New
55
Increased
4
Reduced
8
Closed
25
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHIL.WS
101
DELISTED
Benson Hill, Inc. Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50
BHIL.WS
$28 ﹤0.01%
+20,000
New +$28.2K
ATMR.WS
102
DELISTED
Altimar Acquisition Corp II Warrants
ATMR.WS
$26 ﹤0.01%
25,000
SONDW
103
DELISTED
Sonder Holdings Inc Warrants
SONDW
$21 ﹤0.01%
12,500
CVIIW
104
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$14 ﹤0.01%
15,638
RGTIW icon
105
Rigetti Computing Warrants
RGTIW
$186M
$12 ﹤0.01%
15,387
PRPC.WS
106
DELISTED
CC Neuberger Principal Holdings III Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PRPC.WS
$12 ﹤0.01%
11,480
UHGWW
107
DELISTED
United Homes Group Warrant
UHGWW
$7 ﹤0.01%
12,500
AAL icon
108
American Airlines Group
AAL
$9.88B
-5,000
Closed -$101K
BKSY icon
109
BlackSky Technology
BKSY
$1.3B
-31,063
Closed -$2.48M
CLVT icon
110
Clarivate
CLVT
$1.19B
-250,000
Closed -$23.9M
JOBY icon
111
Joby Aviation
JOBY
$7.87B
-350,000
Closed -$3.5M
OGN icon
112
Organon & Co
OGN
$3.59B
-17,173
Closed -$529K
WTW icon
113
Willis Towers Watson
WTW
$31.6B
-230,171
Closed -$53.2M
ASTSW
114
DELISTED
AST SpaceMobile, Inc. Warrant
ASTSW
-49,074
Closed -$306K
BHIL
115
DELISTED
Benson Hill, Inc.
BHIL
-2,286
Closed -$792K
CANO.WS
116
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
-36,441
Closed -$140K
BODY.WS
117
DELISTED
The Beachbody Company, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
BODY.WS
-33,333
Closed -$99K
EOCW.U
118
DELISTED
Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
EOCW.U
-250,000
Closed -$2.5M
HCNEU
119
DELISTED
Jaws Hurricane Acquisition Corp. Unit
HCNEU
-250,000
Closed -$2.51M
FTVIU
120
DELISTED
FinTech Acquisition Corp. VI Units
FTVIU
-25,000
Closed -$252K
MRACU
121
DELISTED
Marquee Raine Acquisition Corp. Unit
MRACU
-11,970
Closed -$122K
XEC
122
DELISTED
CIMAREX ENERGY CO
XEC
-87,812
Closed -$6.13M
STPC.WS
123
DELISTED
Star Peak Corp II Warrants, each whole warrant exercisable for one share of Class A common stock at
STPC.WS
-20,000
Closed -$36K
SFTW.WS
124
DELISTED
Osprey Technology Acquisition Corp. Redeemable Warrants, each whole Warrant exercisable for one shar
SFTW.WS
-400,000
Closed -$648K
SCPE.WS
125
DELISTED
SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an
SCPE.WS
-300,000
Closed -$618K

Similar funds

Boussard & Gavaudan Investment Management's Q3 2021 Portfolio in Review

As of Q3 2021, Boussard & Gavaudan Investment Management held 164 positions worth $1.18M, down 100% from $1.05B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Boussard & Gavaudan Investment Management withdrew a net $403M in Q3 2021, closing 25 positions and reducing 8 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $115M position sold in full.

By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Boussard & Gavaudan Investment Management opened a new position in BGC Group worth $27.3K.

  • Boussard & Gavaudan Investment Management's largest Q3 2021 buy was BGC Group: 5,236,279 shares worth $27.3K.
  • Boussard & Gavaudan Investment Management added most to Octave Specialty Group in Q3 2021, an estimated $3.11M increase.
  • Boussard & Gavaudan Investment Management's biggest Q3 2021 reduction was Alibaba, cutting an estimated $72.9M.
  • Boussard & Gavaudan Investment Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $115M.
  • Boussard & Gavaudan Investment Management's ten largest holdings make up 51% of its $1.18M portfolio in Q3 2021.
  • Boussard & Gavaudan Investment Management opened 55 new positions and closed 25 in Q3 2021.
  • Boussard & Gavaudan Investment Management's portfolio value fell 100% quarter-over-quarter to $1.18M.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q3 2021, filed 8 Nov 2021.